z-logo
open-access-imgOpen Access
Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT
Author(s) -
Brian P. Rempel,
Eric W. Price,
Christopher P. Phenix
Publication year - 2017
Publication title -
molecular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.815
H-Index - 60
eISSN - 1536-0121
pISSN - 1535-3508
DOI - 10.1177/1536012117717852
Subject(s) - positron emission tomography , enzyme , hydrolysis , molecular imaging , chemistry , emission computed tomography , pet imaging , single photon emission computed tomography , biochemistry , nuclear medicine , medicine , biology , in vivo , microbiology and biotechnology
Hydrolytic enzymes are a large class of biological catalysts that play a vital role in a plethora of critical biochemical processes required to maintain human health. However, the expression and/or activity of these important enzymes can change in many different diseases and therefore represent exciting targets for the development of positron emission tomography (PET) and single-photon emission computed tomography (SPECT) radiotracers. This review focuses on recently reported radiolabeled substrates, reversible inhibitors, and irreversible inhibitors investigated as PET and SPECT tracers for imaging hydrolytic enzymes. By learning from the most successful examples of tracer development for hydrolytic enzymes, it appears that an early focus on careful enzyme kinetics and cell-based studies are key factors for identifying potentially useful new molecular imaging agents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom